Front Run The Week — Free Signals
Get early signals before they hit headlines. Subscribe free — or upgrade for member rewards — at https://tokentrust.substack.com

A tiny biotech nobody was watching just raised $540 million — not for FDA trials, not for M&A, but to build a Digital Asset Treasury and Super Validator operation tied to the institutional blockchain backed by Goldman, Citadel Securities, BNP Paribas, and Circle.

In this episode, Chip Mahoney breaks down why this move matters, how Wall Street is positioning itself behind the scenes, and why this moment may be bigger than the ETF wave. This is where the real rails are being built — and where the real money is going.

Signals — 7-Day Free Trial
Get early market signals, macro indicators, and the projects I’m tracking before they trend. Start your free 7-day trial at https://tokentrust.substack.com

📘 Own The Economy Field Guide
A hands-on workbook that helps you spot signals early, trade with confidence, and align every move with your long-term strategy. Download your copy at https://tokentrust.gumroad.com/l/oteworkbook

🎙 About the Show
The Chip Mahoney Show is a Big Pond production — for entertainment and educational purposes only.

📩 Media & Guest Bookings
DV Collective — dvpodcastshow@gmail.com

🌐 More from Chip
Explore everything I offer — from Substack to OTEC — at https://chipmahoney.com

Music licensed via Spotify Creator Tools.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The $540M Signal: How a Tiny Biotech Exposed Wall Street’s Real Crypto Plan

The Chip Mahoney Show